Form 4: GoodRx CFO Karsten Voermann Reports Stock Transactions
SEC Form 4 Filing
Karsten Voermann, CFO of GoodRx Holdings, Inc., reports the disposition of shares to cover tax obligations upon vesting of restricted stock units.
Summary
- On June 8, 2024, Karsten Voermann, the CFO of GoodRx Holdings, Inc., engaged in transactions involving Class A Common Stock.
- Voermann disposed of 54,064 shares of Class A Common Stock to satisfy tax withholding obligations related to the vesting of restricted stock units.
- Additionally, Voermann disposed of 21,481 shares of Class A Common Stock at a price of $8.55.
- Following these transactions, Voermann directly owns 244,535 shares of Class A Common Stock and 486,576 derivative securities.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC when corporate insiders, like the CFO of GoodRx, engage in transactions involving the company's stock. It provides transparency to the market regarding insider activity.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership by a key executive.
Key Dates
| Date | Description |
|---|---|
| 12/08/2022 | Restricted stock unit award vested as to 6.25% of the underlying shares. |
| 06/08/2024 | Disposition of 54,064 shares of Class A Common Stock and 21,481 shares of Class A Common Stock. |
| 06/10/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.